)
)
Protagonist Therapeutics Inc Investor Relations Material
Latest events
Status Update
Protagonist Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Protagonist Therapeutics Inc
Access all reports
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative peptide-based therapeutic drugs aimed at addressing unmet medical needs. The company's focus encompasses a broad range of diseases, with a particular emphasis on rare and prevalent conditions where existing treatments are limited or inadequate. Protagonist Therapeutics' technology platform has produced a pipeline of promising drug candidates, including peptide-based drugs for hematology and blood disorders, as well as inflammatory and immunomodulatory diseases.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PTGX
Country
🇺🇸 United States